Highbridge Capital Management »

Sellas Life Sciences Group I shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $2.6M 1.8M 1.43
2022-06-30 $223k 100k 2.23

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Occidental Pete Corp Warrant (Principal) (OXY.WS)
Ford Mtr Co Del Bond (Principal)
Occidental Pete Corp Option Put Option
Liberty Broadband Corp Common (LBRDK)
Nice Bond (Principal)
Gamida Cell Bond (Principal)
Sarepta Therapeutics Bond (Principal)
Integra Lifesciences Hldgs C Bond (Principal)
Pdd Holdings Bond (Principal)
American Airlines Group Bond (Principal)
Lci Inds Bond (Principal)
Tilray Brands Bond (Principal)
Omnicell Bond (Principal)
Sea Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Sellas Life Sciences Group I

Alyeska Investment Group
Vanguard Group
Citadel Advisors
Opus Capital Group
Bank of New York Mellon
Virtu Financial
Wells Fargo & Company
Charles Schwab Investment Management
Two Sigma Securities
Commonwealth Equity Services
Millennium Management
Nemes Rush Group
Jpmorgan Chase & Co
Advisor Group Holdings
Royal Bank of Canada

View all funds holding Sellas Life Sciences Group I